Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer

Background Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common ass...

Full description

Saved in:
Bibliographic Details
Published inBMC medicine Vol. 9; no. 1; p. 28
Main Authors Capo-chichi, Callinice D, Cai, Kathy Q, Simpkins, Fiona, Ganjei-Azar, Parvin, Godwin, Andrew K, Xu, Xiang-Xi
Format Journal Article
LanguageEnglish
Published London BioMed Central 26.03.2011
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1741-7015
1741-7015
DOI10.1186/1741-7015-9-28

Cover

Abstract Background Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established. Methods We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells. Results We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21. Conclusions We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer - aberrations in nuclear morphology and aneuploidy.
AbstractList Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established.BACKGROUNDDespite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established.We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells.METHODSWe investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells.We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21.RESULTSWe found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21.We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer--aberrations in nuclear morphology and aneuploidy.CONCLUSIONSWe conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer--aberrations in nuclear morphology and aneuploidy.
Background Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established. Methods We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells. Results We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21. Conclusions We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer - aberrations in nuclear morphology and aneuploidy.
Background Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established. Methods We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells. Results We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21. Conclusions We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer - aberrations in nuclear morphology and aneuploidy.
Abstract Background: Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established. Methods: We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells. Results: We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21. Conclusions: We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer - aberrations in nuclear morphology and aneuploidy.
Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established. We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells. We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21. We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer - aberrations in nuclear morphology and aneuploidy.
Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established. We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells. We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21. We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer--aberrations in nuclear morphology and aneuploidy.
ArticleNumber 28
Audience Academic
Author Capo-chichi, Callinice D
Godwin, Andrew K
Cai, Kathy Q
Xu, Xiang-Xi
Simpkins, Fiona
Ganjei-Azar, Parvin
AuthorAffiliation 2 Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA
1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA
4 Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
6 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA
5 Department of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
3 Ovarian Cancer Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
AuthorAffiliation_xml – name: 4 Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
– name: 6 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA
– name: 3 Ovarian Cancer Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
– name: 1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA
– name: 2 Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA
– name: 5 Department of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
Author_xml – sequence: 1
  givenname: Callinice D
  surname: Capo-chichi
  fullname: Capo-chichi, Callinice D
  organization: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Department of Medicine, University of Miami Miller School of Medicine
– sequence: 2
  givenname: Kathy Q
  surname: Cai
  fullname: Cai, Kathy Q
  organization: Ovarian Cancer Program, Fox Chase Cancer Center
– sequence: 3
  givenname: Fiona
  surname: Simpkins
  fullname: Simpkins, Fiona
  organization: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine
– sequence: 4
  givenname: Parvin
  surname: Ganjei-Azar
  fullname: Ganjei-Azar, Parvin
  organization: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Department of Pathology, University of Miami Miller School of Medicine
– sequence: 5
  givenname: Andrew K
  surname: Godwin
  fullname: Godwin, Andrew K
  organization: Ovarian Cancer Program, Fox Chase Cancer Center, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center
– sequence: 6
  givenname: Xiang-Xi
  surname: Xu
  fullname: Xu, Xiang-Xi
  email: xxu2@med.miami.edu
  organization: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Department of Medicine, University of Miami Miller School of Medicine, Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21439080$$D View this record in MEDLINE/PubMed
BookMark eNqFks1v1DAQxSNURD_gyhFFIMEpre04jnNBqio-KlVwgbPl2JNdV4692Mmi_e-ZZcvSrahQFMWa-b0X-41Pi6MQAxTFS0rOKZXigracVi2hTdVVTD4pTvaFo3vr4-I051tCWNO2_FlxzCivOyLJSeG_zMaDTiWENfi4gjJPaTbTnLQvLQxgplwaPWcozTLFMeY4YifMIyRncOVCnnTvvJs2pQ4WX5hXPjq7wVYZ1zo5HdAhGEjPi6eD9hle3H3Piu8fP3y7-lzdfP10fXV5UxkhxVQ1PRGS6qHWpGX9wCQRYmiNNaalvGG9AADWDj3jtq-5ra0ldU1pT7mlbT_w-qy43vnaqG_VKrlRp42K2qnfhZgWSqfJ4cEVyF73QlDZcsltB1qQhgmD1rWUfdOi18XOaw4rvfmpvd8bUqK2M1DbmNU2ZtUpJlHxfqdYzf0I1kCYMMyDbRx2gluqRVyrGo9bc4EG7-4MUvwxQ57U6LIB7zHbOGclBWU4PEGQfP2AvI1zCpit6gjD4LqmQejNDlpoPLALQ8S_mq2lumRNzTtCGorU-T8ofCyMzuClGxzWDwRv7wmWoP20zNHPk4shH4Kv7uexD-LPJUSA7wCTYs4JBmXcpLc-uAXnH8_5_IHsv4O5G2VGMCwg_U3rEcUvGKoMAQ
CitedBy_id crossref_primary_10_1371_journal_pone_0261181
crossref_primary_10_1007_s00441_014_2069_4
crossref_primary_10_1038_s41419_022_05165_1
crossref_primary_10_1128_MCB_00648_20
crossref_primary_10_1371_journal_pone_0165973
crossref_primary_10_3390_cells10102624
crossref_primary_10_3389_fphar_2023_1338633
crossref_primary_10_4161_nucl_18954
crossref_primary_10_1007_s13402_015_0252_6
crossref_primary_10_1016_j_yexcr_2023_113573
crossref_primary_10_3389_fcell_2023_1173514
crossref_primary_10_3390_cells12050757
crossref_primary_10_1093_hmg_ddaa076
crossref_primary_10_3892_ol_2021_13127
crossref_primary_10_18632_oncotarget_12914
crossref_primary_10_1016_j_anndiagpath_2021_151808
crossref_primary_10_1016_j_drup_2022_100881
crossref_primary_10_1080_19491034_2016_1162933
crossref_primary_10_18632_oncotarget_13854
crossref_primary_10_1091_mbc_E19_09_0520
crossref_primary_10_1186_1755_8166_7_9
crossref_primary_10_1016_j_ygyno_2015_01_531
crossref_primary_10_1093_carcin_bgs022
crossref_primary_10_1186_s12860_017_0125_0
crossref_primary_10_1152_ajpcell_00283_2017
crossref_primary_10_3389_fcell_2022_1068347
crossref_primary_10_1074_jbc_M113_546481
crossref_primary_10_3389_fcell_2021_649899
crossref_primary_10_3390_cells9061340
crossref_primary_10_4161_nucl_27928
crossref_primary_10_1016_j_mce_2015_05_027
crossref_primary_10_1016_j_prp_2023_154560
crossref_primary_10_1093_carcin_bgaa087
crossref_primary_10_58567_ci02020002
crossref_primary_10_1016_j_jbc_2021_101301
crossref_primary_10_3390_cancers15235501
crossref_primary_10_1016_j_addr_2023_114722
crossref_primary_10_58567_ci03010002
crossref_primary_10_1002_gcc_22719
crossref_primary_10_1186_s13027_016_0090_9
crossref_primary_10_1038_nrc3219
crossref_primary_10_1093_nar_gkab761
crossref_primary_10_1186_s40364_018_0144_9
crossref_primary_10_3389_fonc_2018_00529
crossref_primary_10_1016_j_bbcan_2022_188794
crossref_primary_10_1042_BST20200713
crossref_primary_10_1093_hmg_ddac235
crossref_primary_10_1515_mr_2024_0019
crossref_primary_10_1016_j_mad_2016_03_007
crossref_primary_10_1038_s41598_024_70752_5
crossref_primary_10_1186_s12860_016_0114_8
crossref_primary_10_1007_s12010_019_03084_0
crossref_primary_10_1002_sstr_202400571
crossref_primary_10_1158_0008_5472_CAN_24_0169
crossref_primary_10_3390_cancers11020226
crossref_primary_10_1002_cam4_5683
crossref_primary_10_1186_s12885_021_08722_7
crossref_primary_10_31083_j_fbl2806113
crossref_primary_10_1016_j_cca_2024_119992
crossref_primary_10_3390_ijms222011289
crossref_primary_10_1007_s12195_016_0437_8
crossref_primary_10_1016_j_prp_2014_11_008
crossref_primary_10_1016_j_mce_2013_06_016
crossref_primary_10_1002_dc_23941
crossref_primary_10_1016_j_ygyno_2018_10_030
Cites_doi 10.1158/0008-5472.CAN-04-2837
10.1371/journal.pone.0009295
10.1083/jcb.200502148
10.1006/excr.1997.3735
10.1016/S0002-9440(10)63468-2
10.1016/j.febslet.2007.03.052
10.1016/j.gde.2007.02.011
10.1126/science.95.2469.438
10.1093/hmg/ddi479
10.1016/j.ygyno.2009.03.023
10.1002/(SICI)1097-4644(19980801)70:2<172::AID-JCB3>3.0.CO;2-L
10.1073/pnas.0708572104
10.1038/nature03958
10.1016/j.ygyno.2006.03.053
10.1083/jcb.147.5.913
10.1083/jcb.200905057
10.1016/j.ccr.2005.10.017
10.1016/S1535-6108(03)00195-8
10.1016/S0002-9440(10)63708-X
10.1128/MCB.00087-09
10.1038/ng1294-323
10.1126/science.1160058
10.1016/j.ceb.2006.10.002
10.1126/science.307.5706.41d
10.1038/cr.2008.52
10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C
10.1016/j.humpath.2005.07.014
10.1038/nm1266
10.1371/journal.pone.0010358
10.1038/nrg1906
10.2353/ajpath.2006.050564
10.1073/pnas.0730821100
10.1200/JCO.2005.11.650
10.1042/BST0380297
10.1016/0145-2126(90)90076-L
10.1371/journal.pone.0002988
10.1146/annurev.pathol.4.110807.092246
10.1073/pnas.0700854104
10.1038/nrc1430
10.1093/jnci/83.12.862
10.1136/gut.45.5.723
10.1371/journal.pone.0006454
10.1097/01.pas.0000146025.91953.8d
10.1097/PAS.0b013e31802cbbe9
10.1186/1756-9966-28-8
10.1038/nature03099
10.1126/science.1127168
10.1038/6799
10.1091/mbc.11.11.3937
10.1073/pnas.0611640104
10.1111/j.1525-1438.2007.01093.x
10.1016/j.cub.2010.01.034
10.1093/jnci/85.18.1513
10.1074/jbc.M513511200
10.1016/j.ccr.2008.11.011
10.1038/nrm2718
10.1534/genetics.108.090878
10.1242/dev.105.2.365
10.1016/S0021-9258(19)85424-8
10.1242/jcs.114.14.2577
ContentType Journal Article
Copyright Capo-chichi et al; licensee BioMed Central Ltd. 2011 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
COPYRIGHT 2011 BioMed Central Ltd.
2011 Capo-chichi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ©2011 Capo-chichi et al; licensee BioMed Central Ltd. 2011 Capo-chichi et al; licensee BioMed Central Ltd.
Copyright_xml – notice: Capo-chichi et al; licensee BioMed Central Ltd. 2011 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: COPYRIGHT 2011 BioMed Central Ltd.
– notice: 2011 Capo-chichi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright ©2011 Capo-chichi et al; licensee BioMed Central Ltd. 2011 Capo-chichi et al; licensee BioMed Central Ltd.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1186/1741-7015-9-28
DatabaseName Springer Nature Link
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Proquest Central Premium
ProQuest One Academic
ProQuest - Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Publicly Available Content Database



MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen Free (Free internet resource, activated by CARLI)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 6
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1741-7015
EndPage 28
ExternalDocumentID oai_doaj_org_article_e8bab66187484d9ea60526c24d388b57
10.1186/1741-7015-9-28
PMC3072346
2503872501
A253490051
21439080
10_1186_1741_7015_9_28
Genre Research Support, U.S. Gov't, Non-P.H.S
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA079716
– fundername: NCI NIH HHS
  grantid: R01 CA095071
– fundername: NCI NIH HHS
  grantid: CA79716
– fundername: NCI NIH HHS
  grantid: P50 CA83638
– fundername: NCI NIH HHS
  grantid: R01 CA099471
– fundername: NCI NIH HHS
  grantid: R01 CA140323
GroupedDBID ---
0R~
23N
2VQ
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C1A
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
MK0
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
AAYXX
CITATION
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QL
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c686t-5b0681af3a072bf28066f7cdcc71452b6eee27fb24db34d3dd03311b14d17bf43
IEDL.DBID M48
ISSN 1741-7015
IngestDate Wed Aug 27 01:30:33 EDT 2025
Wed Aug 20 00:18:08 EDT 2025
Tue Sep 30 15:53:14 EDT 2025
Wed Oct 01 14:50:49 EDT 2025
Sat Jul 26 02:17:42 EDT 2025
Tue Jun 17 21:48:05 EDT 2025
Tue Jun 10 20:28:59 EDT 2025
Thu May 22 21:21:47 EDT 2025
Mon Jul 21 06:00:56 EDT 2025
Wed Oct 01 01:58:06 EDT 2025
Thu Apr 24 23:02:17 EDT 2025
Sat Sep 06 07:29:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Ovarian Cancer
Aneuploid Cell
Ovarian Cancer Cell
Nuclear Envelope
Nuclear Morphology
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c686t-5b0681af3a072bf28066f7cdcc71452b6eee27fb24db34d3dd03311b14d17bf43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/902280955?pq-origsite=%requestingapplication%
PMID 21439080
PQID 902280955
PQPubID 42775
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_e8bab66187484d9ea60526c24d388b57
unpaywall_primary_10_1186_1741_7015_9_28
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3072346
proquest_miscellaneous_861208060
proquest_journals_902280955
gale_infotracmisc_A253490051
gale_infotracacademiconefile_A253490051
gale_healthsolutions_A253490051
pubmed_primary_21439080
crossref_citationtrail_10_1186_1741_7015_9_28
crossref_primary_10_1186_1741_7015_9_28
springer_journals_10_1186_1741_7015_9_28
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-03-26
PublicationDateYYYYMMDD 2011-03-26
PublicationDate_xml – month: 03
  year: 2011
  text: 2011-03-26
  day: 26
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC medicine
PublicationTitleAbbrev BMC Med
PublicationTitleAlternate BMC Med
PublicationYear 2011
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References Hsu, Kurman, Vang, Wang, Baak, Shih (CR4) 2005; 36
Capo-chichi, Cai, Testa, Godwin, Xu (CR39) 2009; 29
Lammerding, Fong, Ji, Reue, Stewart, Young, Lee (CR23) 2006; 281
Scaffidi, Misteli (CR29) 2006; 312
Weaver, Cleveland (CR17) 2006; 18
Singer, Stöhr, Cope, Dehari, Hartmann, Cao, Wang, Kurman, Shih (CR63) 2005; 29
Shih, Kurman (CR46) 2004; 164
Dechat, Shimi, Adam, Rusinol, Andres, Spielmann, Sinensky, Goldman (CR56) 2007; 104
Cai, Wu, Klein-Szanto, Xu (CR62) 2009; 114
Pienta, Coffey (CR2) 1991; 68
Smith, Cai, Smedberg, Ribeiro, Rula, Slater, Godwin, Xu (CR43) 2010; 5
Liu, Rolef Ben-Shahar, Riemer, Treinin, Spann, Weber, Fire, Gruenbaum (CR49) 2000; 11
Liu, Wang, Chan, Tjia, Deng, Guan, Huang, Li, Chau, Chen, Pei, Pendas, Cadiñanos, López-Otín, Tse, Hutchison, Chen, Cao, Cheah, Tryggvason, Zhou (CR54) 2005; 11
Nickerson (CR10) 1998; 70
Cai, Caslini, Capo-chichi, Slater, Smith, Wu, Klein-Szanto, Godwin, Xu (CR40) 2009; 4
Melcon, Kozlov, Cutler, Sullivan, Hernandez, Zhao, Mitchell, Nader, Bakay, Rottman, Hoffman, Stewart (CR52) 2006; 15
Cai, Klein-Szanto, Karthik, Edelson, Daly, Ozols, Lynch, Godwin, Xu (CR41) 2006; 103
Hudson, Pozdnyakova, Haines, Mor, Snyder (CR38) 2007; 104
Boyd, Pienta, Getzenberg, Coffey, Barrett (CR7) 1991; 83
Röber, Weber, Osborn (CR25) 1989; 105
Wu, Wu, Weng, Xu, Geng, Zhao (CR36) 2009; 28
Palmer, Sant Cassia, Irwin, Morris, Rollason (CR6) 2008; 18
Farley, Ozbun, Birrer (CR61) 2008; 18
Roschke, Tonon, Gehlhaus, McTyre, Bussey, Lababidi, Scudiero, Weinstein, Kirsch (CR13) 2003; 63
Kohler, Marks, Wiseman, Jacobs, Davidoff, Clarke-Pearson, Soper, Bast, Berchuck (CR64) 1993; 85
Duesberg (CR16) 2005; 307
Boveri (CR11) 1914
Dehari, Kurman, Logani, Shih (CR5) 2007; 31
Thompson, Bakhoum, Compton (CR14) 2010; 20
Debes, Sebo, Heemers, Kipp, Haugen, Lohse, Tindall (CR9) 2005; 65
Bonne, Di Barletta, Varnous, Becane, Hammouda, Merlini, Muntoni, Greenberg, Gary, Urtizberea, Duboc, Fardeau, Toniolo, Schwartz (CR27) 1999; 21
Torres, Williams, Amon (CR57) 2008; 179
Vaughan, Alvarez-Reyes, Bridger, Broers, Ramaekers, Wehnert, Morris, Whitfield, Hutchison (CR44) 2001; 114
Bione, Maestrini, Rivella, Mancini, Regis, Romeo, Toniolo (CR28) 1994; 8
Pothuri, Leitao, Levine, Viale, Olshen, Arroyo, Bogomolniy, Olvera, Lin, Soslow, Robson, Offit, Barakat, Boyd (CR18) 2010; 5
Thompson, Compton (CR45) 2010; 188
Margolis (CR21) 2005; 8
Willis, Cox, Rahman-Casañs, Smits, Przyborski, van den Brandt, van Engeland, Weijenberg, Wilson, de Bruïne, Hutchison (CR34) 2008; 3
Lin, Worman (CR24) 1993; 268
Machiels, Broers, Raymond, de Ley, Kuijpers, Caberg, Ramaekers (CR37) 1995; 67
Moss, Krivosheyev, de Souza, Chin, Gaetz, Chaudhary, Worman, Holt (CR35) 1999; 45
Agrelo, Setien, Espada, Artiga, Rodriguez, Pérez-Rosado, Sanchez-Aguilera, Fraga, Piris, Esteller (CR33) 2005; 23
Weaver, Cleveland (CR60) 2008; 14
Papanicolaou (CR3) 1942; 95
Cho, Shih (CR47) 2009; 4
Liu, Lee, Segura-Totten, Neufeld, Wilson, Gruenbaum (CR50) 2003; 100
Capell, Collins (CR30) 2006; 7
Ozawa, Hayashi, Ogawa, Kurokawa, Matsumoto, Noguchi, Nonaka, Nishino (CR53) 2006; 168
Foster, Przyborski, Wilson, Hutchison (CR31) 2010; 38
Shi, King (CR20) 2005; 437
Williams, Prabhu, Hunter, Glazier, Whittaker, Housman, Amon (CR58) 2008; 322
Ganem, Storchova, Pellman (CR19) 2007; 17
Gorjánácz, Jaedicke, Mattaj (CR48) 2007; 581
Stadelmann, Khandjian, Hirt, Lüthy, Weil, Wagner (CR32) 1990; 14
Lammerding, Hsiao, Schulze, Kozlov, Stewart, Lee (CR22) 2005; 170
Zink, Fischer, Nickerson (CR1) 2004; 4
Fischer, Taysavang, Jhiang (CR8) 2003; 163
Sullivan, Escalante-Alcalde, Bhatt, Anver, Bhat, Nagashima, Stewart, Burke (CR51) 1999; 147
Capo-chichi, Roland, Vanderveer, Bao, Yamagata, Hirai, Cohen, Hamilton, Godwin, Xu (CR42) 2003; 63
Holland, Cleveland (CR12) 2009; 10
Lin, Worman (CR26) 1997; 236
Rajagopalan, Lengauer (CR15) 2004; 432
Cao, Capell, Erdos, Djabali, Collins (CR55) 2007; 104
Pihan, Doxsey (CR59) 2003; 4
G Pihan (376_CR59) 2003; 4
BC Capell (376_CR30) 2006; 7
J Liu (376_CR49) 2000; 11
SL Thompson (376_CR14) 2010; 20
J Farley (376_CR61) 2008; 18
T Dechat (376_CR56) 2007; 104
AJ Holland (376_CR12) 2009; 10
A Vaughan (376_CR44) 2001; 114
M Gorjánácz (376_CR48) 2007; 581
K Cho (376_CR47) 2009; 4
F Lin (376_CR26) 1997; 236
SF Moss (376_CR35) 1999; 45
IM Shih (376_CR46) 2004; 164
B Pothuri (376_CR18) 2010; 5
K Cao (376_CR55) 2007; 104
B Liu (376_CR54) 2005; 11
AV Roschke (376_CR13) 2003; 63
T Boveri (376_CR11) 1914
G Bonne (376_CR27) 1999; 21
Z Wu (376_CR36) 2009; 28
B Stadelmann (376_CR32) 1990; 14
ER Smith (376_CR43) 2010; 5
CD Capo-chichi (376_CR42) 2003; 63
GN Papanicolaou (376_CR3) 1942; 95
NJ Ganem (376_CR19) 2007; 17
KQ Cai (376_CR62) 2009; 114
F Lin (376_CR24) 1993; 268
D Zink (376_CR1) 2004; 4
H Rajagopalan (376_CR15) 2004; 432
ME Hudson (376_CR38) 2007; 104
T Sullivan (376_CR51) 1999; 147
G Melcon (376_CR52) 2006; 15
ND Willis (376_CR34) 2008; 3
JD Debes (376_CR9) 2005; 65
P Duesberg (376_CR16) 2005; 307
J Lammerding (376_CR23) 2006; 281
BA Weaver (376_CR60) 2008; 14
CD Capo-chichi (376_CR39) 2009; 29
CR Foster (376_CR31) 2010; 38
KJ Pienta (376_CR2) 1991; 68
KQ Cai (376_CR40) 2009; 4
Q Shi (376_CR20) 2005; 437
G Singer (376_CR63) 2005; 29
BM Machiels (376_CR37) 1995; 67
J Lammerding (376_CR22) 2005; 170
R Ozawa (376_CR53) 2006; 168
J Boyd (376_CR7) 1991; 83
JA Nickerson (376_CR10) 1998; 70
EM Torres (376_CR57) 2008; 179
S Bione (376_CR28) 1994; 8
CY Hsu (376_CR4) 2005; 36
RL Margolis (376_CR21) 2005; 8
R Agrelo (376_CR33) 2005; 23
J Liu (376_CR50) 2003; 100
RA Röber (376_CR25) 1989; 105
JE Palmer (376_CR6) 2008; 18
BR Williams (376_CR58) 2008; 322
AH Fischer (376_CR8) 2003; 163
KQ Cai (376_CR41) 2006; 103
SL Thompson (376_CR45) 2010; 188
R Dehari (376_CR5) 2007; 31
BA Weaver (376_CR17) 2006; 18
MF Kohler (376_CR64) 1993; 85
P Scaffidi (376_CR29) 2006; 312
16698071 - Gynecol Oncol. 2006 Nov;103(2):719-28
1655233 - Cancer. 1991 Nov 1;68(9):2012-6
19581290 - Mol Cell Biol. 2009 Sep;29(17):4766-77
20334839 - Curr Biol. 2010 Mar 23;20(6):R285-95
16115958 - J Cell Biol. 2005 Aug 29;170(5):781-91
15644779 - Am J Surg Pathol. 2005 Feb;29(2):218-24
17324569 - Curr Opin Genet Dev. 2007 Apr;17(2):157-62
10517909 - Gut. 1999 Nov;45(5):723-9
17418822 - FEBS Lett. 2007 Jun 19;581(15):2794-801
15549096 - Nature. 2004 Nov 18;432(7015):338-41
18842102 - Annu Rev Pathol. 2009;4:287-313
16226103 - Hum Pathol. 2005 Oct;36(10):1049-54
14695175 - Cancer Res. 2003 Dec 15;63(24):8634-47
17954908 - Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17494-9
19546858 - Nat Rev Mol Cell Biol. 2009 Jul;10(7):478-87
2680424 - Development. 1989 Feb;105(2):365-78
2232854 - Leuk Res. 1990;14(9):815-21
15637254 - Science. 2005 Jan 7;307(5706):41
17046232 - Curr Opin Cell Biol. 2006 Dec;18(6):658-67
9367621 - Exp Cell Res. 1997 Nov 1;236(2):378-84
10080180 - Nat Genet. 1999 Mar;21(3):285-8
11071918 - Mol Biol Cell. 2000 Nov;11(11):3937-47
20174585 - PLoS One. 2010;5(2):e9295
8521872 - Eur J Cell Biol. 1995 Aug;67(4):328-35
16507906 - Am J Pathol. 2006 Mar;168(3):907-17
17944918 - Int J Gynecol Cancer. 2008 Jul-Aug;18(4):692-701
15111296 - Am J Pathol. 2004 May;164(5):1511-8
19649254 - PLoS One. 2009;4(7):e6454
11683386 - J Cell Sci. 2001 Jul;114(Pt 14):2577-90
16403804 - Hum Mol Genet. 2006 Feb 15;15(4):637-51
18427574 - Cell Res. 2008 May;18(5):538-48
12941822 - Cancer Res. 2003 Aug 15;63(16):4967-77
8360934 - J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9
2061946 - J Natl Cancer Inst. 1991 Jun 19;83(12):862-6
12937150 - Am J Pathol. 2003 Sep;163(3):1091-100
18558649 - Genetics. 2008 Jun;179(2):737-46
16825190 - J Biol Chem. 2006 Sep 1;281(35):25768-80
7894480 - Nat Genet. 1994 Dec;8(4):323-7
20074078 - Biochem Soc Trans. 2010 Feb;38(Pt 1):297-300
19375154 - Gynecol Oncol. 2009 Jul;114(1):18-25
12957283 - Cancer Cell. 2003 Aug;4(2):89-94
18974345 - Science. 2008 Oct 31;322(5902):703-9
15705864 - Cancer Res. 2005 Feb 1;65(3):708-12
16222248 - Nature. 2005 Oct 13;437(7061):1038-42
17139325 - Nat Rev Genet. 2006 Dec;7(12):940-52
20436685 - PLoS One. 2010;5(4):e10358
15867203 - J Clin Oncol. 2005 Jun 10;23(17):3940-7
18714339 - PLoS One. 2008;3(8):e2988
10579712 - J Cell Biol. 1999 Nov 29;147(5):913-20
8344919 - J Biol Chem. 1993 Aug 5;268(22):16321-6
16645051 - Science. 2006 May 19;312(5776):1059-63
12684533 - Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4598-603
17360326 - Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4955-60
19061834 - Cancer Cell. 2008 Dec 9;14(6):431-3
17592266 - Am J Surg Pathol. 2007 Jul;31(7):1007-12
17360355 - Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4949-54
16286243 - Cancer Cell. 2005 Nov;8(5):353-4
15343274 - Nat Rev Cancer. 2004 Sep;4(9):677-87
9671223 - J Cell Biochem. 1998 Aug 1;70(2):172-80
20123995 - J Cell Biol. 2010 Feb 8;188(3):369-81
19144202 - J Exp Clin Cancer Res. 2009;28:8
15980864 - Nat Med. 2005 Jul;11(7):780-5
17842594 - Science. 1942 Apr 24;95(2469):438-9
References_xml – volume: 65
  start-page: 708
  year: 2005
  end-page: 712
  ident: CR9
  article-title: p300 modulates nuclear morphology in prostate cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-2837
– volume: 5
  start-page: e9295
  year: 2010
  ident: CR43
  article-title: Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009295
– volume: 170
  start-page: 781
  year: 2005
  end-page: 791
  ident: CR22
  article-title: Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200502148
– volume: 236
  start-page: 378
  year: 1997
  end-page: 384
  ident: CR26
  article-title: Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and B1 genes
  publication-title: Exp Cell Res
  doi: 10.1006/excr.1997.3735
– volume: 163
  start-page: 1091
  year: 2003
  end-page: 1100
  ident: CR8
  article-title: Nuclear envelope irregularity is induced by RET/PTC during interphase
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63468-2
– volume: 581
  start-page: 2794
  year: 2007
  end-page: 2801
  ident: CR48
  article-title: What can Caenorhabditis elegans tell us about the nuclear envelope?
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.03.052
– volume: 17
  start-page: 157
  year: 2007
  end-page: 162
  ident: CR19
  article-title: Tetraploidy, aneuploidy and cancer
  publication-title: Curr Opin Genet Dev
  doi: 10.1016/j.gde.2007.02.011
– volume: 95
  start-page: 438
  year: 1942
  end-page: 439
  ident: CR3
  article-title: A new procedure for staining vaginal smears
  publication-title: Science
  doi: 10.1126/science.95.2469.438
– volume: 15
  start-page: 637
  year: 2006
  end-page: 651
  ident: CR52
  article-title: Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddi479
– volume: 114
  start-page: 18
  year: 2009
  end-page: 25
  ident: CR62
  article-title: Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2009.03.023
– volume: 70
  start-page: 172
  year: 1998
  end-page: 180
  ident: CR10
  article-title: Nuclear dreams: the malignant alteration of nuclear architecture
  publication-title: J Cell Biochem
  doi: 10.1002/(SICI)1097-4644(19980801)70:2<172::AID-JCB3>3.0.CO;2-L
– volume: 104
  start-page: 17494
  year: 2007
  end-page: 17499
  ident: CR38
  article-title: Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0708572104
– volume: 437
  start-page: 1038
  year: 2005
  end-page: 1042
  ident: CR20
  article-title: Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines
  publication-title: Nature
  doi: 10.1038/nature03958
– volume: 103
  start-page: 719
  year: 2006
  end-page: 728
  ident: CR41
  article-title: Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2006.03.053
– volume: 147
  start-page: 913
  year: 1999
  end-page: 920
  ident: CR51
  article-title: Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy
  publication-title: J Cell Biol
  doi: 10.1083/jcb.147.5.913
– volume: 188
  start-page: 369
  year: 2010
  end-page: 381
  ident: CR45
  article-title: Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200905057
– volume: 8
  start-page: 353
  year: 2005
  end-page: 354
  ident: CR21
  article-title: Tetraploidy and tumor development
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.10.017
– volume: 4
  start-page: 89
  year: 2003
  end-page: 94
  ident: CR59
  article-title: Mutations and aneuploidy: co-conspirators in cancer?
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00195-8
– volume: 114
  start-page: 2577
  year: 2001
  end-page: 2590
  ident: CR44
  article-title: Both emerin and lamin C depend on lamin A for localization at the nuclear envelope
  publication-title: J Cell Sci
– volume: 164
  start-page: 1511
  year: 2004
  end-page: 1518
  ident: CR46
  article-title: Ovarian tumorigenesis - a proposed model based on morphological and molecular genetic analysis
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63708-X
– volume: 29
  start-page: 4766
  year: 2009
  end-page: 4777
  ident: CR39
  article-title: Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00087-09
– volume: 8
  start-page: 323
  year: 1994
  end-page: 327
  ident: CR28
  article-title: Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy
  publication-title: Nat Genet
  doi: 10.1038/ng1294-323
– volume: 322
  start-page: 703
  year: 2008
  end-page: 709
  ident: CR58
  article-title: Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells
  publication-title: Science
  doi: 10.1126/science.1160058
– volume: 18
  start-page: 658
  year: 2006
  end-page: 667
  ident: CR17
  article-title: Does aneuploidy cause cancer?
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2006.10.002
– volume: 307
  start-page: 41
  year: 2005
  ident: CR16
  article-title: Does aneuploidy or mutation start cancer?
  publication-title: Science
  doi: 10.1126/science.307.5706.41d
– volume: 63
  start-page: 4967
  year: 2003
  end-page: 4977
  ident: CR42
  article-title: Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis
  publication-title: Cancer Res
– volume: 18
  start-page: 538
  year: 2008
  end-page: 548
  ident: CR61
  article-title: Genomic analysis of epithelial ovarian cancer
  publication-title: Cell Res
  doi: 10.1038/cr.2008.52
– volume: 68
  start-page: 2012
  year: 1991
  end-page: 2016
  ident: CR2
  article-title: Correlation of nuclear morphometry with progression of breast cancer
  publication-title: Cancer
  doi: 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C
– volume: 36
  start-page: 1049
  year: 2005
  end-page: 1054
  ident: CR4
  article-title: Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2005.07.014
– volume: 11
  start-page: 780
  year: 2005
  end-page: 785
  ident: CR54
  article-title: Genomic instability in laminopathy-based premature aging
  publication-title: Nat Med
  doi: 10.1038/nm1266
– volume: 5
  start-page: e10358
  year: 2010
  ident: CR18
  article-title: Genetic analysis of the early natural history of epithelial ovarian carcinoma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010358
– volume: 7
  start-page: 940
  year: 2006
  end-page: 952
  ident: CR30
  article-title: Human laminopathies: nuclei gone genetically awry
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg1906
– volume: 168
  start-page: 907
  year: 2006
  end-page: 917
  ident: CR53
  article-title: Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.050564
– volume: 100
  start-page: 4598
  year: 2003
  end-page: 4603
  ident: CR50
  article-title: MAN1 and emerin have overlapping function(s) essential for chromosome segregation and cell division in Caenorhabditis elegans
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0730821100
– volume: 63
  start-page: 8634
  year: 2003
  end-page: 8647
  ident: CR13
  article-title: Karyotypic complexity of the NCI-60 drug-screening panel
  publication-title: Cancer Res
– volume: 23
  start-page: 3940
  year: 2005
  end-page: 3947
  ident: CR33
  article-title: Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.11.650
– volume: 38
  start-page: 297
  year: 2010
  end-page: 300
  ident: CR31
  article-title: Lamins as cancer biomarkers
  publication-title: Biochem Soc Trans
  doi: 10.1042/BST0380297
– volume: 67
  start-page: 328
  year: 1995
  end-page: 335
  ident: CR37
  article-title: Abnormal A-type lamin organization in a human lung carcinoma cell line
  publication-title: Eur J Cell Biol
– volume: 268
  start-page: 16321
  year: 1993
  end-page: 16326
  ident: CR24
  article-title: Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C
  publication-title: J Biol Chem
– volume: 14
  start-page: 815
  year: 1990
  end-page: 821
  ident: CR32
  article-title: Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells
  publication-title: Leuk Res
  doi: 10.1016/0145-2126(90)90076-L
– volume: 3
  start-page: e2988
  year: 2008
  ident: CR34
  article-title: Lamin A/C is a risk biomarker in colorectal cancer
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0002988
– volume: 4
  start-page: 287
  year: 2009
  end-page: 313
  ident: CR47
  article-title: Ovarian cancer
  publication-title: Annual Review Pathol
  doi: 10.1146/annurev.pathol.4.110807.092246
– volume: 104
  start-page: 4955
  year: 2007
  end-page: 4960
  ident: CR56
  article-title: Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0700854104
– volume: 4
  start-page: 677
  year: 2004
  end-page: 687
  ident: CR1
  article-title: Nuclear structure in cancer cells
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1430
– volume: 83
  start-page: 862
  year: 1991
  end-page: 866
  ident: CR7
  article-title: Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/83.12.862
– volume: 45
  start-page: 723
  year: 1999
  end-page: 729
  ident: CR35
  article-title: Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms
  publication-title: Gut
  doi: 10.1136/gut.45.5.723
– volume: 4
  start-page: e6454
  year: 2009
  ident: CR40
  article-title: Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006454
– volume: 29
  start-page: 218
  year: 2005
  end-page: 224
  ident: CR63
  article-title: Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation
  publication-title: Am J Surg Pathol
  doi: 10.1097/01.pas.0000146025.91953.8d
– volume: 105
  start-page: 365
  year: 1989
  end-page: 378
  ident: CR25
  article-title: Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study
  publication-title: Development
– volume: 31
  start-page: 1007
  year: 2007
  end-page: 1012
  ident: CR5
  article-title: The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31802cbbe9
– volume: 28
  start-page: e8
  year: 2009
  ident: CR36
  article-title: Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-28-8
– volume: 432
  start-page: 338
  year: 2004
  end-page: 341
  ident: CR15
  article-title: Aneuploidy and cancer
  publication-title: Nature
  doi: 10.1038/nature03099
– volume: 312
  start-page: 1059
  year: 2006
  end-page: 1063
  ident: CR29
  article-title: Lamin A-dependent nuclear defects in human aging
  publication-title: Science
  doi: 10.1126/science.1127168
– volume: 21
  start-page: 285
  year: 1999
  end-page: 288
  ident: CR27
  article-title: Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
  publication-title: Nature Genet
  doi: 10.1038/6799
– volume: 11
  start-page: 3937
  year: 2000
  end-page: 3947
  ident: CR49
  article-title: Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.11.11.3937
– volume: 104
  start-page: 4949
  year: 2007
  end-page: 4954
  ident: CR55
  article-title: A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0611640104
– year: 1914
  ident: CR11
  publication-title: Zur Frage der Enstehung maligner Tumoren
– volume: 18
  start-page: 692
  year: 2008
  end-page: 701
  ident: CR6
  article-title: The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma
  publication-title: Int J Gynecol Cancer
  doi: 10.1111/j.1525-1438.2007.01093.x
– volume: 20
  start-page: 285
  year: 2010
  end-page: 295
  ident: CR14
  article-title: Mechanisms of chromosomal instability
  publication-title: Curr Biol
  doi: 10.1016/j.cub.2010.01.034
– volume: 85
  start-page: 1513
  year: 1993
  end-page: 1519
  ident: CR64
  article-title: Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/85.18.1513
– volume: 281
  start-page: 25768
  year: 2006
  end-page: 25780
  ident: CR23
  article-title: Lamins A and C but not lamin B1 regulate nuclear mechanics
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M513511200
– volume: 14
  start-page: 431
  year: 2008
  end-page: 433
  ident: CR60
  article-title: The aneuploidy paradox in cell growth and tumorigenesis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2008.11.011
– volume: 10
  start-page: 478
  year: 2009
  end-page: 487
  ident: CR12
  article-title: Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2718
– volume: 179
  start-page: 737
  year: 2008
  end-page: 746
  ident: CR57
  article-title: Aneuploidy: cells losing their balance
  publication-title: Genetics
  doi: 10.1534/genetics.108.090878
– volume: 38
  start-page: 297
  year: 2010
  ident: 376_CR31
  publication-title: Biochem Soc Trans
  doi: 10.1042/BST0380297
– volume: 179
  start-page: 737
  year: 2008
  ident: 376_CR57
  publication-title: Genetics
  doi: 10.1534/genetics.108.090878
– volume: 63
  start-page: 4967
  year: 2003
  ident: 376_CR42
  publication-title: Cancer Res
– volume: 18
  start-page: 538
  year: 2008
  ident: 376_CR61
  publication-title: Cell Res
  doi: 10.1038/cr.2008.52
– volume: 581
  start-page: 2794
  year: 2007
  ident: 376_CR48
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.03.052
– volume-title: Zur Frage der Enstehung maligner Tumoren
  year: 1914
  ident: 376_CR11
– volume: 114
  start-page: 18
  year: 2009
  ident: 376_CR62
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2009.03.023
– volume: 312
  start-page: 1059
  year: 2006
  ident: 376_CR29
  publication-title: Science
  doi: 10.1126/science.1127168
– volume: 188
  start-page: 369
  year: 2010
  ident: 376_CR45
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200905057
– volume: 100
  start-page: 4598
  year: 2003
  ident: 376_CR50
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0730821100
– volume: 36
  start-page: 1049
  year: 2005
  ident: 376_CR4
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2005.07.014
– volume: 4
  start-page: 89
  year: 2003
  ident: 376_CR59
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00195-8
– volume: 7
  start-page: 940
  year: 2006
  ident: 376_CR30
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg1906
– volume: 11
  start-page: 3937
  year: 2000
  ident: 376_CR49
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.11.11.3937
– volume: 8
  start-page: 323
  year: 1994
  ident: 376_CR28
  publication-title: Nat Genet
  doi: 10.1038/ng1294-323
– volume: 23
  start-page: 3940
  year: 2005
  ident: 376_CR33
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.11.650
– volume: 437
  start-page: 1038
  year: 2005
  ident: 376_CR20
  publication-title: Nature
  doi: 10.1038/nature03958
– volume: 103
  start-page: 719
  year: 2006
  ident: 376_CR41
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2006.03.053
– volume: 15
  start-page: 637
  year: 2006
  ident: 376_CR52
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddi479
– volume: 3
  start-page: e2988
  year: 2008
  ident: 376_CR34
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0002988
– volume: 28
  start-page: e8
  year: 2009
  ident: 376_CR36
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-28-8
– volume: 168
  start-page: 907
  year: 2006
  ident: 376_CR53
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.050564
– volume: 8
  start-page: 353
  year: 2005
  ident: 376_CR21
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.10.017
– volume: 83
  start-page: 862
  year: 1991
  ident: 376_CR7
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/83.12.862
– volume: 14
  start-page: 815
  year: 1990
  ident: 376_CR32
  publication-title: Leuk Res
  doi: 10.1016/0145-2126(90)90076-L
– volume: 29
  start-page: 4766
  year: 2009
  ident: 376_CR39
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00087-09
– volume: 5
  start-page: e9295
  year: 2010
  ident: 376_CR43
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009295
– volume: 65
  start-page: 708
  year: 2005
  ident: 376_CR9
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-2837
– volume: 18
  start-page: 658
  year: 2006
  ident: 376_CR17
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2006.10.002
– volume: 95
  start-page: 438
  year: 1942
  ident: 376_CR3
  publication-title: Science
  doi: 10.1126/science.95.2469.438
– volume: 20
  start-page: 285
  year: 2010
  ident: 376_CR14
  publication-title: Curr Biol
  doi: 10.1016/j.cub.2010.01.034
– volume: 21
  start-page: 285
  year: 1999
  ident: 376_CR27
  publication-title: Nature Genet
  doi: 10.1038/6799
– volume: 432
  start-page: 338
  year: 2004
  ident: 376_CR15
  publication-title: Nature
  doi: 10.1038/nature03099
– volume: 31
  start-page: 1007
  year: 2007
  ident: 376_CR5
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31802cbbe9
– volume: 104
  start-page: 17494
  year: 2007
  ident: 376_CR38
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0708572104
– volume: 104
  start-page: 4949
  year: 2007
  ident: 376_CR55
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0611640104
– volume: 85
  start-page: 1513
  year: 1993
  ident: 376_CR64
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/85.18.1513
– volume: 10
  start-page: 478
  year: 2009
  ident: 376_CR12
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2718
– volume: 29
  start-page: 218
  year: 2005
  ident: 376_CR63
  publication-title: Am J Surg Pathol
  doi: 10.1097/01.pas.0000146025.91953.8d
– volume: 4
  start-page: 677
  year: 2004
  ident: 376_CR1
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1430
– volume: 70
  start-page: 172
  year: 1998
  ident: 376_CR10
  publication-title: J Cell Biochem
  doi: 10.1002/(SICI)1097-4644(19980801)70:2<172::AID-JCB3>3.0.CO;2-L
– volume: 105
  start-page: 365
  year: 1989
  ident: 376_CR25
  publication-title: Development
  doi: 10.1242/dev.105.2.365
– volume: 4
  start-page: 287
  year: 2009
  ident: 376_CR47
  publication-title: Annual Review Pathol
  doi: 10.1146/annurev.pathol.4.110807.092246
– volume: 164
  start-page: 1511
  year: 2004
  ident: 376_CR46
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63708-X
– volume: 147
  start-page: 913
  year: 1999
  ident: 376_CR51
  publication-title: J Cell Biol
  doi: 10.1083/jcb.147.5.913
– volume: 268
  start-page: 16321
  year: 1993
  ident: 376_CR24
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)85424-8
– volume: 11
  start-page: 780
  year: 2005
  ident: 376_CR54
  publication-title: Nat Med
  doi: 10.1038/nm1266
– volume: 4
  start-page: e6454
  year: 2009
  ident: 376_CR40
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006454
– volume: 5
  start-page: e10358
  year: 2010
  ident: 376_CR18
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010358
– volume: 14
  start-page: 431
  year: 2008
  ident: 376_CR60
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2008.11.011
– volume: 307
  start-page: 41
  year: 2005
  ident: 376_CR16
  publication-title: Science
  doi: 10.1126/science.307.5706.41d
– volume: 163
  start-page: 1091
  year: 2003
  ident: 376_CR8
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63468-2
– volume: 63
  start-page: 8634
  year: 2003
  ident: 376_CR13
  publication-title: Cancer Res
– volume: 114
  start-page: 2577
  year: 2001
  ident: 376_CR44
  publication-title: J Cell Sci
  doi: 10.1242/jcs.114.14.2577
– volume: 281
  start-page: 25768
  year: 2006
  ident: 376_CR23
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M513511200
– volume: 236
  start-page: 378
  year: 1997
  ident: 376_CR26
  publication-title: Exp Cell Res
  doi: 10.1006/excr.1997.3735
– volume: 67
  start-page: 328
  year: 1995
  ident: 376_CR37
  publication-title: Eur J Cell Biol
– volume: 322
  start-page: 703
  year: 2008
  ident: 376_CR58
  publication-title: Science
  doi: 10.1126/science.1160058
– volume: 170
  start-page: 781
  year: 2005
  ident: 376_CR22
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200502148
– volume: 68
  start-page: 2012
  year: 1991
  ident: 376_CR2
  publication-title: Cancer
  doi: 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C
– volume: 45
  start-page: 723
  year: 1999
  ident: 376_CR35
  publication-title: Gut
  doi: 10.1136/gut.45.5.723
– volume: 104
  start-page: 4955
  year: 2007
  ident: 376_CR56
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0700854104
– volume: 17
  start-page: 157
  year: 2007
  ident: 376_CR19
  publication-title: Curr Opin Genet Dev
  doi: 10.1016/j.gde.2007.02.011
– volume: 18
  start-page: 692
  year: 2008
  ident: 376_CR6
  publication-title: Int J Gynecol Cancer
  doi: 10.1111/j.1525-1438.2007.01093.x
– reference: 12941822 - Cancer Res. 2003 Aug 15;63(16):4967-77
– reference: 17944918 - Int J Gynecol Cancer. 2008 Jul-Aug;18(4):692-701
– reference: 18558649 - Genetics. 2008 Jun;179(2):737-46
– reference: 15644779 - Am J Surg Pathol. 2005 Feb;29(2):218-24
– reference: 15980864 - Nat Med. 2005 Jul;11(7):780-5
– reference: 17842594 - Science. 1942 Apr 24;95(2469):438-9
– reference: 15705864 - Cancer Res. 2005 Feb 1;65(3):708-12
– reference: 17324569 - Curr Opin Genet Dev. 2007 Apr;17(2):157-62
– reference: 16226103 - Hum Pathol. 2005 Oct;36(10):1049-54
– reference: 8360934 - J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9
– reference: 16698071 - Gynecol Oncol. 2006 Nov;103(2):719-28
– reference: 12684533 - Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4598-603
– reference: 19581290 - Mol Cell Biol. 2009 Sep;29(17):4766-77
– reference: 17360355 - Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4949-54
– reference: 16645051 - Science. 2006 May 19;312(5776):1059-63
– reference: 16286243 - Cancer Cell. 2005 Nov;8(5):353-4
– reference: 16507906 - Am J Pathol. 2006 Mar;168(3):907-17
– reference: 8344919 - J Biol Chem. 1993 Aug 5;268(22):16321-6
– reference: 17954908 - Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17494-9
– reference: 1655233 - Cancer. 1991 Nov 1;68(9):2012-6
– reference: 10517909 - Gut. 1999 Nov;45(5):723-9
– reference: 16115958 - J Cell Biol. 2005 Aug 29;170(5):781-91
– reference: 18842102 - Annu Rev Pathol. 2009;4:287-313
– reference: 15343274 - Nat Rev Cancer. 2004 Sep;4(9):677-87
– reference: 16825190 - J Biol Chem. 2006 Sep 1;281(35):25768-80
– reference: 10579712 - J Cell Biol. 1999 Nov 29;147(5):913-20
– reference: 2061946 - J Natl Cancer Inst. 1991 Jun 19;83(12):862-6
– reference: 16222248 - Nature. 2005 Oct 13;437(7061):1038-42
– reference: 18714339 - PLoS One. 2008;3(8):e2988
– reference: 11071918 - Mol Biol Cell. 2000 Nov;11(11):3937-47
– reference: 20074078 - Biochem Soc Trans. 2010 Feb;38(Pt 1):297-300
– reference: 15867203 - J Clin Oncol. 2005 Jun 10;23(17):3940-7
– reference: 18427574 - Cell Res. 2008 May;18(5):538-48
– reference: 17139325 - Nat Rev Genet. 2006 Dec;7(12):940-52
– reference: 19061834 - Cancer Cell. 2008 Dec 9;14(6):431-3
– reference: 19375154 - Gynecol Oncol. 2009 Jul;114(1):18-25
– reference: 9671223 - J Cell Biochem. 1998 Aug 1;70(2):172-80
– reference: 19144202 - J Exp Clin Cancer Res. 2009;28:8
– reference: 20334839 - Curr Biol. 2010 Mar 23;20(6):R285-95
– reference: 8521872 - Eur J Cell Biol. 1995 Aug;67(4):328-35
– reference: 10080180 - Nat Genet. 1999 Mar;21(3):285-8
– reference: 7894480 - Nat Genet. 1994 Dec;8(4):323-7
– reference: 2680424 - Development. 1989 Feb;105(2):365-78
– reference: 17360326 - Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4955-60
– reference: 15637254 - Science. 2005 Jan 7;307(5706):41
– reference: 14695175 - Cancer Res. 2003 Dec 15;63(24):8634-47
– reference: 20436685 - PLoS One. 2010;5(4):e10358
– reference: 15111296 - Am J Pathol. 2004 May;164(5):1511-8
– reference: 17418822 - FEBS Lett. 2007 Jun 19;581(15):2794-801
– reference: 12957283 - Cancer Cell. 2003 Aug;4(2):89-94
– reference: 9367621 - Exp Cell Res. 1997 Nov 1;236(2):378-84
– reference: 12937150 - Am J Pathol. 2003 Sep;163(3):1091-100
– reference: 18974345 - Science. 2008 Oct 31;322(5902):703-9
– reference: 20123995 - J Cell Biol. 2010 Feb 8;188(3):369-81
– reference: 15549096 - Nature. 2004 Nov 18;432(7015):338-41
– reference: 16403804 - Hum Mol Genet. 2006 Feb 15;15(4):637-51
– reference: 19546858 - Nat Rev Mol Cell Biol. 2009 Jul;10(7):478-87
– reference: 19649254 - PLoS One. 2009;4(7):e6454
– reference: 17592266 - Am J Surg Pathol. 2007 Jul;31(7):1007-12
– reference: 17046232 - Curr Opin Cell Biol. 2006 Dec;18(6):658-67
– reference: 11683386 - J Cell Sci. 2001 Jul;114(Pt 14):2577-90
– reference: 20174585 - PLoS One. 2010;5(2):e9295
– reference: 2232854 - Leuk Res. 1990;14(9):815-21
SSID ssj0025774
Score 2.27044
Snippet Background Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and...
Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of...
Background Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and...
Abstract Background: Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for...
Abstract Background Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis...
SourceID doaj
unpaywall
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 28
SubjectTerms Aneuploidy
Bank acquisitions & mergers
Biomedicine
Cell growth
Chromosomes
Experiments
Female
Flow Cytometry
Gene Expression Profiling
Gene mutations
Gene Silencing
Genetic aspects
Health aspects
Human subjects
Humans
In Situ Hybridization, Fluorescence
Lamin Type A - biosynthesis
Medicine
Medicine & Public Health
Microscopy, Fluorescence
Mutation
Nuclear Envelope - pathology
Nuclear Envelope - ultrastructure
Ovarian cancer
Ovarian Neoplasms - complications
Ovarian Neoplasms - pathology
Ovary - pathology
Proteins
Research Article
Risk factors
RNA Interference
Studies
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDzwOiHdDC_iARC9WEyfx41gQVYXUnqjUm-VX1JVCsup2QfvvmXGyYQOqeuGQS2Y2smfG81iPPxPy0fogZa1zpnWT4xVmNXMhFIwHnUP0aoSq8Lzz-YU4u6y-XdVXO1d9YU_YAA88CO44KmcdBBGFoJdBRysQocTzKpRKuTqdI4cwti2mxlKrlgl_GdLtgkmIeCNcY6HE8fSOaYZ3sO-Eo4Ta_69v3glOfzdOTrunT8ijdbe0m1-2bXcC1Okz8nTMLOnJMKPn5EHsXpCH5-Pe-UvSXiB0sb2hsUt9QpEO2LGIu0FDTG0d1Nv1KlJ_jU16q_4HULr1sKfT0gVmkqmXdkNtF-CJ62XbL8IGSLT_CVW37eALYEY3r8jl6dfvX87YeNcC80KJW1a7XKjCNqXNJXcN7reKRvrgvSyqmjsRY-SycSB3V4LsQ8jLsihcUYVCuqYqX5O9ru_iPqEIISigSrR5EyvdgP40l0EFK7W0rnIZYVuRGz8CkeN9GK1JBYkSBlVkUEVGG64y8mniXw4QHHdyfkYNTlwInZ1egEGZ0aDMfQaVkQ-ofzOcQ50cgDnhdVlpdGIwoMSBLgAG7u14kgGmj2BaM87DGScsXT8jH2xtzIyuY2V0QijSdZ0ROlHxh9gN18V-vTIK0lLI9EWekTeDQU5T5pD_aqBlRM5MdSaTOaVbXCdYcfD2vKxERo62Rv1nUHfJ-2gy-ntU8_Z_qOaAPB7-0i8ZF4dkD1ZJfAc54a17n5b_b9iFWbM
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagSDwOiDehBXxAoherefpxQgVRVUjtiUp7s_wKXSkky24XtP-eGSebbkCFQy47s5HteXicGX9DyDvjvBCVSplSdYotzCpmvc9Y7lUKu1fNZYn3nc_O-elF-WVWzYbanNVQVrn1idFR-87hN_IjFYFbVFV9WPxg2DQKk6tDB43b5E4GkQoqtZhdn7cqCG0GnMZM8iOIvTMmYPtjimHz9Z19KML1_-2Ud3alPysmx7TpA3Jv3S7M5pdpmp2d6eQReTiElPS414HH5FZon5C7Z0PS_ClpzhGz2CxpaGOBUKA9aCwCblAfYj0HdWa9CtRdYnXeqvsOlHbdJ3MaOscQMhbRbqhpPTxhvWi6ud8AiXY_4bhtWngD6M_yGbk4-fz10ykbmiwwxyW_YpVNucxMXZhU5LbGRCuvhfPOiayscstDCLmobV56W5S-8D4tiiyzWekzYeuyeE722q4NLwlF7EAOx0OT1qFUtbRG5cJLb4QSxpY2IWy75NoNCOTYCKPR8SQiuUYRaRSRVjqXCXk_8i967I0bOT-iBEcuxMyOP3TLb3owQR1gQBbCEYnwqV4FwxHrxsHECiltJRLyFuWv-wuoo-Xr47wqSoXeCwYUOdD2YeDODFcYYPqIojXhPJhwgs26CXl_q2N68BkrPWp4QuhIxT9iGVwbuvVKS4hHIcTnaUJe9Ao5TjmHwFcBLSFioqqTNZlS2vllxBMHN58XJU_I4Vaprwd103ofjkr_H9G8-udU98n9_iN9wXJ-QPZA_cNriPKu7Jtoy78BYxFPgA
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature Link
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagSDwOiDehBXJAoheLxPHzWFZUFVJ7olJvll9RV0qzq24XtP-emSQbNlQVHPayM4lsz9OZ8WdCPrkQlRKmoMbUBV5hJqiPsaQsmgKiVy01x_POp2fy5Jx_vxAXQ4MsnoXZrd-XWn6BhLmkCmIWNZTp--SBAKeLrXszORs3VgJymAGQ8fYzk4DT4fLf9r474efv1sixPvqEPFq3S7f55ZpmJwQdPyNPh9wxP-qF_ZzcS-0L8vB0qI6_JM0ZghO76zy1XSdQynt0WETWyGPqGjfy4NarlIdLbMNbLa6A0q77qk2TzzFX7LplN7lrI_zSetks5nEDpHzxE_bVroU3gKJcvyLnx99-zE7ocJsCDVLLGyp8IXXp6soVivkaK6qyViGGoEoumJcpJaZqz3j0FY9VjEVVlaUveSyVr3n1muy1iza9JTmCBErYB7qiTtzU2jvDVNTRKaOc5z4jdLvkNgxQ43jjRWO7LYeWFkVkUUTWWKYz8nnkX_YgG3dyfkUJjlwIjt39ATpjB1uzCQbkIe_QiJMaTXISQW0CTKzS2guVkY8of9ufNB1N3B4xUXGDbgoG1HGgkcPAgxvOKsD0ES5rwnkw4QTjDBPy_lbH7OAcVtZ0GERGiIzkIxUfxH63Ni3WK6sh8YRcXhYZedMr5DhlBhmuAVpG1ERVJ2sypbTzyw44HPw5q7jMyOFWqf8M6q71PhyV_h-ieff_b90nj_tP8xVl8oDsgS2k95Db3fgPnWH_BiTmRqw
  priority: 102
  providerName: Springer Nature
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6VVOJx4P0wLeADEr04tdf2Po4BUVVIjTgQqZxW-zKNcJ0oiUHh1zPrtU3cqoIDh1wyY2t3PK_VzHyL0FupDaU5jyPOi9hdYZZHypgkwobHEL0KwjI373w2Jaez7NN5fr6HTrtZGHWpu6LyeHcAvfTzDe7-BLs6XprCmzsjx5BSJxGFqBbxCLNbaJ-4UtMI7c-mnydf_TykZ2gxG68_NIhJDXT_dQe9E6Gudk_2JdR76E5dLeX2pyzLnSh18gDNu_355pTv43qjxvrXFejH_yGAh-h-m8qGE697j9CerR6j22fta5-gcuqwkuUqtFXTmGRDD1brgD5CY5s-klDLem1DfeG6AteLS6BUtS8ileHcpa5N8-42lJWBn62X5WJutkAKFz_gmC8reAPo7eopmp18_PLhNGovd4g0YWQT5SomLJFFKmOKVeEKvKSg2mhNkyzHilhrMS0UzoxKM5MaE6dpkqgkMwlVRZY-Q6NqUdkXKHSYhQSOpTIubMYLpiTH1DAjKadSZSpAUfd5hW6Rz90FHKVoTkCMCCdC4UQouMAsQO96_qXH_LiR873Tlp7LYXU3fyxW30Rr-sLCghSkQczBthpuJXEYOxo2ljKmchqgN07XhB987T2OmOA8zbjzmrCghsP5HFi4lu3oBGzfoXcNOA8HnOAr9IB80OmzaH3VWvAGEonneYDCnuoedO13lV3Ua8EgD4ajBYkD9Nwrf79lDAk3B1qA6MAsBjIZUqr5RYNjDuEFpxkJ0FFnQH8WdZO8j3oD-8unefnvrAforq8UpBEmh2gEtmBfQaq5Ua9bL_IbtN941w
  priority: 102
  providerName: Unpaywall
Title Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer
URI https://link.springer.com/article/10.1186/1741-7015-9-28
https://www.ncbi.nlm.nih.gov/pubmed/21439080
https://www.proquest.com/docview/902280955
https://www.proquest.com/docview/861208060
https://pubmed.ncbi.nlm.nih.gov/PMC3072346
https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/1741-7015-9-28
https://doaj.org/article/e8bab66187484d9ea60526c24d388b57
UnpaywallVersion publishedVersion
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMed Central Open Access Free
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: RBZ
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: KQ8
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: KQ8
  dateStart: 20031101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: DOA
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: ABDBF
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: DIK
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: GX1
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: M~E
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central (Free e-resource, activated by CARLI)
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: RPM
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: M48
  dateStart: 20031101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: HAS SpringerNature Open Access 2022
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: AAJSJ
  dateStart: 20031201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerOpen Free (Free internet resource, activated by CARLI)
  customDbUrl:
  eissn: 1741-7015
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025774
  issn: 1741-7015
  databaseCode: C6C
  dateStart: 20031201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Za9tAEF5yQI-H0rtqUlcPheZFjc49HkpxTEIo2IRQg9uXZVe7agyq7NhxW__7zqxkNWoa8iCDPCOxx8zOrGb2G0LeqdwwlokwEKIIsYRZFmhjoiA2IgTrVVCe4nnn4YiejtPPk2yyRTapvM0ALv-7tcN6UuNF-eH35foTKPxHp_CcHoJTHQUM7Fog8KTx_DLAolIYfG0qbGyTXTBUMQr9MG2DDCCsDqS5fbzBdLz5yo7NctD-Nxfwaxbs3-zKNsT6kNxfVXO1_qXK8poVO3lMHjXup9-v5eUJ2bLVU3Jv2ATYn5FyhPjGauHbyiUTWb8GmEVwDt9Yl_vh52q1tH5-gZl8y9kPoFSrOvBT-lN0N13C7dpXlYHLrublbGrWQPJnP2Frrip4A8ja4jkZnxx_GZwGTUGGIKecXgWZDimPVJGokMW6wKAsLVhu8pxFaRZraq2NWaHj1OgkNYkxYZJEkY5SEzFdpMkLslPNKvuK-IgzSGErqcLCpqLgWomYGW4UE0zpVHsk2Ay5zBu0ciyaUUq3a-FU4hRJnCIpZMw98r7ln9c4HbdyHuEMtlyIr-3-mC2-y0ZdpYUGaXBdOEKtGmEVRVycHDqWcK4z5pG3OP-yPqzarhKyH2dJKnClgwY5DpRcaHiumuMO0H1E3Opw7nc4Qb_zDnlvI2Nyox5SOBgjkWUe8VsqPogpc5WdrZaSg-8K2wEaeuRlLZBtl2NwkgXQPMI6otoZky6lml447HEwCXGSUo8cbIT6b6NuG--DVujvmJrXd3dmjzyov-onQUz3yQ7ogH0DbuGV7pFtNmE9snt0PDo7h7sBHfTcJ5aeU3v4PT_6BvTx6Kz_9Q_yjWRL
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSgcEG9CC80BRC9RE8ex4wNC5VFtaXdPrbQ3Y8cOXSkky26Xan8U_5GZvLoLKpx6yCUzG9me8cx4Z_wNIa91ZoVIZBhImYfYwiwJjLVRQK0MwXvlPGV433k44oMz9mWcjDfIr-4uDJZVdjaxNtS2yvA_8n1ZA7fIJHk__RFg0yhMrnYdNBqtOHbLSzixzd8dfQLxvqH08PPpx0HQNhUIMp7yiyAxIU8jncc6FNTkmFjkuchslomIJdRw5xwVuaHMmpjZ2NowjqPIRMxGwuQshu_eIrdZHDKE6hfjq_NdAqFUiwsZpXwfYv0oEOBuAxlgs_cVv1e3B_jbCax4wT8rNPs07T2ytSinenmpi2LFEx4-IPfbENY_aHTuIdlw5SNyZ9gm6R-TYoQYyXrmu7IuSHJ-A1KLAB--dXX9iJ_pxdz52TlWA86r70ApF03yqPAnGLLWRbtLX5cWHreYFtXELoHkVz_heK9L-ALo6-wJObuR9X9KNsuqdM-Jj1iFHI6jOswdk3lqtKTCplYLKbRhxiNBt-QqaxHPsfFGoeqTT8oVikihiJRUNPXI255_2mB9XMv5ASXYcyFGd_2imn1T7ZZXDgZkIPxJEa7VSqc5YutkMLE4TU0iPLKL8lfNhdfe0qgDmsRMorWEAdUcaGtg4Jlur0zA9BG1a41zZ40TbES2Rt7udEy1Nmqu-h3lEb-n4g-x7K501WKuUoh_4UjBQ488axSynzKFQFsCzSNiTVXX1mSdUk7Oa_xycCs0Ztwje51SXw3quvXe65X-P6J58c-p7pKtwenwRJ0cjY63yd0mQRAHlO-QTdgK7iVEmBfmVb2vffL1pg3Jb816jLQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKKxU4IN6EFpoDEr1YTZz4JXFZHquy0BUSVOrN8it0pZCs9gHaf884yYaGqoLDXnYmke2ZsWcyM58ReqWt45zKBEtZJOEKM4qNcykmTiZwehVM5KHf-WzKTs_zyQW92EFvtr0wTbX7NiXZ9jQElKZqdTJ3RWvigp2AG51iDicZlpiIW2hPUMkg9NobjSZfJ33ARcG36YAarz81OIgavP7ru_KVY-nvksk-b3oX3V5Xc735pcvyytE0vo_udT5lPGqV4AHa8dVDtH_WZc0foXIaQIv1IvZVUyHk4xY1NiBuxM43BR2x1eulj-1lKM9b1j-AUq3bbE4Zz4IP2VTRbmJdOfj59bysZ24DpLj-CfG2ruANoECLx-h8_OHbu1Pc3bKALRNshalJmEh1kemEE1OETCsruHXW8jSnxDDvPeGFIbkzWe4y55IsS1OT5i7lpsizJ2i3qiv_DMUBPJBBfKiTwueyEEZLwp1wmkuuTW4ihLdLrmwHQR5uwihVE4oIpoKIVBCRkoqICL3u-ect-MaNnG-DBHuuAJrd_FEvvqvOBpWHARnwR0TAT3XSaxbAbixMLBPCUB6hoyB_1Xag9qavRoRmuQzbFwyo4QjGDwO3uuthgOkHGK0B5-GAE4zWDsgHWx1T3aaxVLLBJpKURijuqeHBUAdX-Xq9VAIcUvDxWRKhp61C9lMm4PlKoEWID1R1sCZDSjW7bADFYZ8nWc4idLxV6j-Dumm9j3ul_4donv__W4_Q_pf3Y_X54_TTAbrTfr3PMGGHaBfMwr8A929lXnZW_hsVEFNX
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6VVOJx4P0wLeADEr04tdf2Po4BUVVIjTgQqZxW-zKNcJ0oiUHh1zPrtU3cqoIDh1wyY2t3PK_VzHyL0FupDaU5jyPOi9hdYZZHypgkwobHEL0KwjI373w2Jaez7NN5fr6HTrtZGHWpu6LyeHcAvfTzDe7-BLs6XprCmzsjx5BSJxGFqBbxCLNbaJ-4UtMI7c-mnydf_TykZ2gxG68_NIhJDXT_dQe9E6Gudk_2JdR76E5dLeX2pyzLnSh18gDNu_355pTv43qjxvrXFejH_yGAh-h-m8qGE697j9CerR6j22fta5-gcuqwkuUqtFXTmGRDD1brgD5CY5s-klDLem1DfeG6AteLS6BUtS8ileHcpa5N8-42lJWBn62X5WJutkAKFz_gmC8reAPo7eopmp18_PLhNGovd4g0YWQT5SomLJFFKmOKVeEKvKSg2mhNkyzHilhrMS0UzoxKM5MaE6dpkqgkMwlVRZY-Q6NqUdkXKHSYhQSOpTIubMYLpiTH1DAjKadSZSpAUfd5hW6Rz90FHKVoTkCMCCdC4UQouMAsQO96_qXH_LiR873Tlp7LYXU3fyxW30Rr-sLCghSkQczBthpuJXEYOxo2ljKmchqgN07XhB987T2OmOA8zbjzmrCghsP5HFi4lu3oBGzfoXcNOA8HnOAr9IB80OmzaH3VWvAGEonneYDCnuoedO13lV3Ua8EgD4ajBYkD9Nwrf79lDAk3B1qA6MAsBjIZUqr5RYNjDuEFpxkJ0FFnQH8WdZO8j3oD-8unefnvrAforq8UpBEmh2gEtmBfQaq5Ua9bL_IbtN941w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nuclear+envelope+structural+defects+cause+chromosomal+numerical+instability+and+aneuploidy+in+ovarian+cancer&rft.jtitle=BMC+medicine&rft.au=Capo-chichi%2C+Callinice+D&rft.au=Cai%2C+Kathy+Q&rft.au=Simpkins%2C+Fiona&rft.au=Ganjei-Azar%2C+Parvin&rft.date=2011-03-26&rft.issn=1741-7015&rft.eissn=1741-7015&rft.volume=9&rft.spage=28&rft_id=info:doi/10.1186%2F1741-7015-9-28&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon